''there must be an underlying influence causing such incredibly nice data reported by Fujii et al. ' ' 1 In retrospect, we deeply regret that the affected journals did not pursue these concerns at that time.
Looking back to 2011, I alerted Dr. Ryoichi Ochiai, Professor of Anesthesiology at Toho University School of Medicine, to concerns regarding the implausibility of certain elements of the data presented in Dr. Fujii's manuscript on colforsin daropate submitted to the Journal. This notification triggered the launch of an internal investigation at Toho University. I was subsequently advised that Dr. Fujii's article had no ethically approved protocol, and furthermore, there would be no means to prove the authenticity of the data or the validity of the study itself. The Journal rejected this article as a result of the departmental investigation, leaving the extent of further actions to be determined by the University. Shortly thereafter, a more extensive review of Dr. Fujii's work was launched by the Investigating Committee of the Faculty of Medicine at Toho University. The University Discipline Committee's findings were released in March 2012 and referred to studies (Appendix, available as Electronic Supplementary Material) published in other journals that had been conducted without Ethics Committee approval. In its statement, the University exonerated co-author Dr. Michiyo Itakura. Toho University subsequently organized a Disciplinary Committee which ruled disciplinary dismissal appropriate, and Dr. Fujii was summarily dismissed on February 29, 2012.
In March 2012, a detailed and innovative analysis of 168 randomized controlled trials written by Dr. Fujii from 1999-2011 as either primary author or a co-author was Electronic supplementary material The online version of this article (doi:10.1007/s12630-012-9802-9) contains supplementary material, which is available to authorized users. published in Anaesthesia.
2 This analysis, written by Dr. John Carlisle, provides an overwhelming statistical argument that ''the distribution of continuous and categorical variables reported in Fujii's papers, both animal and human, are extremely unlikely to have arisen by chance and, if so, in many cases with likelihoods that are infinitesimally small.'' The analysis showed that the published distributions of 28/33 variables across studies were encountered with expected distributions such that ''their likelihood of occurrence ranged from one in 25 to less than one in 10 33 ''. On behalf of the editors of the affected journals, Dr. Steven Shafer, Editor-in-Chief of Anesthesia & Analgesia, wrote the Deans of the Faculties of Medicine of the six universities in Japan from which Dr. Fujii had prior affiliations to alert the institutions of these concerns and to notify them of the articles written by Dr. Kranke et al. and Dr. Carlisle.
B The universities were asked to provide unequivocal evidence of Institutional Review Board approval and data veracity regarding each of the 168 studies cited in the Carlisle article plus an additional 23 suspect papers. In their Joint Statement, the editors identified that the review would be complex as it involved a number of institutions, and they emphasized that, ''in the absence of the aforementioned documentation, it is possible that many or all of the affected articles may be retracted in due course.'' Over the ensuing months, the institutions in Japan reported their findings. The JA Toride Medical Center found no documentation or Institutional Review Board (IRB) approval for any of the 49 articles written by Dr. Fujii while he was at that centre. Toho University reported that eight of 25 articles they reviewed had no evidence of IRB approval, and furthermore, 11 of the 25 articles were review articles that made reference to some of Dr. Fujii's problematic papers; hence, the investigating committee did not recognize the scientific propriety of these articles either. Tokyo Medical and Dental University investigated 13 articles; three of the articles were deemed to have been cases of properly conducted studies where Dr. Fujii The notice also explains that the University of Tsukuba has affirmed the validity of three articles [3] [4] [5] published in the Journal that were written by Dr. S. Takahashi and co-authored by Dr. Fujii. In addition, Tokyo Medical and Dental University affirmed the legitimacy of two other articles published in the Journal; one article was written by Dr. T. Ebata 6 and the other by Dr. Y. Saitoh 7 ; both articles were co-authored by Dr. Fujii. The above five articles shall remain part of the unimpeached medical literature. Individual retraction notes for each of the 17 articles listed in Table 1 appear in this issue of the Journal. The 17 articles by Dr. Fujii listed in Table 2 remain under review by the University of Tsukuba and are considered compromised until they are assessed by the University. Articles in Table 2 that are not affirmed as valid by the University of Tsukuba will be retracted.
It is usually considered to be the responsibility of universities to investigate cases of suspected scientific and/or ethical misconduct and to take appropriate disciplinary action when such cases are confirmed. It is the duty of the affected journals to undertake the retractions. While journals generally recognize only the findings of institutional investigations, in this instance, the Japanese Society of Anesthesiologists ' investigation extended and corroborated the findings of the investigating committees at the universities where Dr. Fujii had previously worked. In addition, the Japanese Society of Anesthesiologists' statement also addresses how Dr. Fujii could have published so many fabricated articles. The statement is made that, ''In order to be easily accepted by journals, he [Dr. Fujii] fabricated in most his papers that he studied large numbers of cases in a randomized controlled trial in double-blind manner.'' In addition, ''the name of the institution and the period of study have not been specific in his papers so that 'he could excuse that the data were obtained at a previously worked hospital or in a place where he took a part-time job'.'' In many articles, the affiliated institutions of the research ethics boards were not identified, and furthermore, Dr. Fujii made it appear that many articles were multiauthored studies by placing names of other institutions along with his list of co-authors. The Japanese Society of Anesthesiologists' statement also states that ''all fabrications were done by Dr. Fujii alone''. The reason he included the names of co-authors on the papers was apparently a tactic ''to escape from suspicions of fraud''.
We deeply regret the negative impact that will be generated by retracting such a large body of scientific literature from this journal and others. These retractions, and others yet to come, occur just a little more than a year following retraction of the Boldt articles. 8 Twelve of the 17 articles written by Dr. Fujii that have now been retracted describe clinical trials in adult and pediatric populations ostensibly evaluating the antiemetic efficacy of granisetron. Three of these 17 studies describe results relating to the efficacy of various pharmacological interventions, including dobutamine, nicardipine, and amrinone, to attenuate diaphragmatic fatigue in a canine model. In general, health practice and policy is rarely changed based on the results of a single primary study. More often, changes in clinical practice evolve gradually after one or more systematic reviews or practice guidelines (resulting from a systematic review). In the case of Dr. Fujii's retracted articles, it will be important to ascertain the impact of his primary research that has been included in systematic reviews, as such results could be potentially misleading until such time as they can be re-analyzed without the problem primary studies.
On behalf of the Journal's Editorial Board, we extend our sincerest thanks to the universities in Japan that undertook the very difficult task to investigate. In particular, we extend our appreciation to Dr. Ryoichi Ochiai, Professor of Anesthesiology at Toho University in Japan, On considère habituellement qu'il incombe aux universités d'enquêter sur les cas suspects de fraude scientifique et/ou de comportement non éthique, et de prendre les mesures disciplinaires appropriées quand de tels cas sont confirmés. C'est le devoir des revues concernées d'entreprendre les rétractions. Bien que les revues ne reconnaissent habituellement que les constatations des enquêtes menées par les institutions, dans le cas Tableau 1 Articles rétractés du Journal canadien d'anesthésie présent, l'enquête de la Société japonaise des anesthésiologistes a amplifié et corroboré les constatations des comités d'enquêtes des universités dans lesquelles le Dr Fujii avait travaillé antérieurement. De plus, la déclaration de la Société japonaise des anesthésiologistes aborde également la façon dont le Dr Fujii a pu publier autant d'articles falsifiés. Il y est précisé qu' « afin que ses articles soient facilement acceptés par les revues, il [le Dr Fujii] a faussement déclaré que dans la plupart de ses articles, il avait étudié de grands nombres de cas dans des études randomisées, contrôlées, à double insu ». De plus, le nom de l'institution et la période de l'étude n'étaient pas spécifiés dans ses articles de telle sorte « qu'il pouvait trouver des excuses pour les données obtenues dans des hôpitaux où il avait travaillé précédemment ou à temps partiel ». Dans de nombreux articles, les comités d'éthique de la recherche des institutions affiliées n'étaient pas identifiés et le Dr Fujii donnait également à penser que de nombreux articles reposaient sur les études de multiples auteurs en plaçant les noms d'autres institutions avec la liste de ses coauteurs. La déclaration de la Société japonaise des anesthésiologistes affirme également que « toutes les falsifications sont la responsabilité du seul Dr Fujii ». La raison pour laquelle il avait inclus les noms de coauteurs était apparemment une tactique « destinée à échapper aux soupçons de fraude ».
Nous regrettons sincèrement l'impact négatif qui sera créé par la rétractation d'une telle masse de publications scientifiques dans ce journal et dans d'autres. Ces rétractations, et d'autres encore à venir, surviennent à peine un peu plus d'un an après la rétractation des articles de Boldt. 8 Douze des 17 articles rédigés par le Dr Fujii qui ont été maintenant rétractés décrivent des études cliniques sur des populations adultes et pédiatriques qui évaluaient ostensiblement l'efficacité antiémétique du granisétron. Trois de ces 17 articles décrivent des résultats ayant trait à l'efficacité de diverses interventions pharmacologiques incluant la dobutamine, la nicardipine et l'amrinone dans le but d'atténuer la fatigue diaphragmatique dans un modèle canin. D'une manière générale, les pratiques et directives de santé sont rarement changées au vu des résultats d'une seule étude originale. Plus souvent, la pratique clinique n'évolue que progressivement, après une ou plusieurs analyses systématiques ou de nouvelles lignes directrices Tableau 2 Articles rédigés par Dr Yoshitaka Fujii dont le statut est indéterminé (résultant d'une analyse systématique). Dans le cas des articles du Dr Fujii qui ont été rétractés, il sera important de s'assurer de l'impact de sa recherche originale sur les analyses systématiques dans lesquelles elle a été incluse, car de tels résultats pourraient éventuellement fausser des décisions jusqu'à ce qu'une nouvelle analyse excluant les études problématiques soit réalisée.
Nous tenons, au nom du Comité éditorial du Journal à exprimer nos sincères remerciements aux universités japonaises qui ont entrepris la très difficile tâche que constituait cette enquête. Nous tenons à remercier particulièrement le Dr Ryoichi Ochiai, professeur d'anesthésiologie à l'université Toho, au Japon, le Dr Steven Shafer, rédacteur en chef d'Anesthesia & Analgesia, et le Dr Steven Yentis, rédacteur en chef d'Anaesthesia. Bien qu'il sera toujours difficile de détecter un fraudeur expérimenté, nous pouvons seulement espérer qu'une plus grande supervision par toutes les universités, un respect des exigences des directives de publications validées et une plus grande rigueur dans l'évaluation éditoriale par les pairs minimiseront ou élimineront la probabilité d'une nouvelle fraude en série aussi gigantesque.
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